| Literature DB >> 32944198 |
Szymon Jarosławski1, Bożena Jarosławska2, Barbara Błaszczyk3, Pascal Auqier1, Mondher Toumi1.
Abstract
BACKGROUND: Ischaemic stroke (IS) is a major cause of death and disability and affects the quality of life of patients. Previous studies focused on urban populations.Entities:
Keywords: Stroke; anxiety; cognitive function; depression; quality of life
Year: 2020 PMID: 32944198 PMCID: PMC7482738 DOI: 10.1080/20016689.2020.1775933
Source DB: PubMed Journal: J Mark Access Health Policy ISSN: 2001-6689
Knowledge of the principles of secondary prevention of stroke and compliance with its recommendations.
| Area of knowledge of and compliance with the recommendations received at hospital discharge | n | % |
|---|---|---|
| Knowing your blood pressure | 120 | 69.8 |
| Knowledge of the range of a normal blood pressure | 18 | 10.5 |
| Measurement of blood pressure at home | 118 | 68.6 |
| Knowledge of weight | 135 | 78.5 |
| Knowledge of appropriate weight range | 102 | 59.3 |
| Knowledge of your glucose levels | 42 | 24.4 |
| Knowledge of normal glucose levels range | 38 | 22.1 |
| Knowing your cholesterol level | 28 | 16.3 |
| Knowledge of normal cholesterol level range | 21 | 12.2 |
| Quit smoking | 11 | 32.4 (% of smokers) |
| Limited smoking | 12 | 69.8 |
| Lost weight | 38 | 22.1 |
| Increased physical activity | 38 | 22.1 |
| Changed diet | 50 | 29.1 |
| Prevention of secondary stroke at the time of assessment: | ||
| Only aspirin | 132 | 76.7 |
| Aspirin and other anti-platelet medication | 15 | 8.7 |
| Ticlopidine | 1 | 0.6 |
| Anticoagulants | 37 | 88.1 (% of patients with AF) |
| The lack of pharmaco-prevention | 11 | 6.4 |
| Statin drugs | 77 | 44.8 |
| Endarterectomy | 1 | 0.6 |
| Angioplasty | 3 | 1.7 |
| Rehabilitation | 96 | 55.8 |
| Speech therapy | 7 | 13.2 (% of patients with aphasia) |
AF: atrial fibrillation
Figure 1.Results of the EQ-5D survey. Sample size n = 171.
Figure 2.EQ-VAS results. Sample size n = 171.
Summary of factors affecting the results of the evaluation with questionnaires EQ-5 D and SF-12 using univariate and multivariate analysis.
| Age | Education | Previous stroke | Rankin scale rating | The presence of paresis | Speech disorders | Barthel scale assessment | Anxiety | Depression | Subsequent stroke | Dementia | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EQ mobility | x | x | x | x | X * | x | X * | x | x | ||
| EQ self-care | x | x | x | X * | x | X * | X * | x | x | ||
| EQ usual activities | x | x | X * | x | X * | X * | X * | ||||
| EQ pain/discomfort | X * | x | x | x | X * | x | x | ||||
| EQ anxiety/depression | X * | x | * | X * | x | ||||||
| EQ VAS | x | x | X * | X * | x | x | |||||
| SF PCS | x | X * | x | X * | x | X * | X * | x | x | ||
| SF MCS | x | X * | X * | x | |||||||
| SF PF | x | x | x | X * | X * | X * | x | X * | x | x | |
| SF RP | x | x | x | x | X * | X * | x | x | |||
| SF BP | X * | x | X * | X * | x | ||||||
| SF GH | X * | x | x | X * | X * | x | |||||
| SF VT | x | x | x | x | X * | X * | x | x | |||
| SF SF | x | X * | X * | x | |||||||
| SF RE | X * | X * | X * | x | |||||||
| SF MH | x | X * | X * | X * |
* – confirmed with regression test
x- univariate analysis
X- multivariate analysis
EQ: EuroQol-5D, SF: Short Form-12, BP: Body Pain, GH: General Health, MCS: Mental Health Composite Scale, MH: Mental Health, PCS: Physical Composite Scale, PF: Physical Functioning, RE: Role Emotional, RP: Role Physical, SF: Social Functioning, VT: Vitality
The complete numeric data is available as Supplementary Material 1.
Results of the SF-12 survey. Sample size n = 169.
| Physical Health Scores | Mental Health Scores | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| PCS | MCS | PF | RP | BP | GH | VT | SF | RE | MH |
| 34.37 | 43.90 | 35.88 | 34.03 | 44.36 | 30.73 | 34.59 | 42.77 | 42.49 | 44.02 |
Values are mean scores. BP: Body Pain, GH: General Health, MCS: Mental Health Composite Scale, MH: Mental Health, PCS: Physical Composite Scale, PF: Physical Functioning, RE: Role Emotional, RP: Role Physical, SF: Social Functioning, VT: Vitality. Further details can be consulted in Supplementary Material 2.